MHRA Issues Class 2 Medicines Recall Drug Alert
The Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom has issued a drug alert concerning a class 2 medicines recall of paracetamol tablets.
The Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom has issued a drug alert concerning a class 2 medicines recall of paracetamol tablets on June 13, 2019.
The drug recall, which has been instigated by M & A Pharmachem-manufacturer of the paracetamol tablets in question, has been issued as a result of a small number of pots from each batch being found to be discolored due to fungal contamination. In the alert, it is noted that the fungi have been identified as Penicillium citrinium and Penicillium brevicompactum, although it is not thought that any tablets will have made it to patients as the discoloration is noticeable once the pack is opened.
Advice for healthcare professionals and wholesalers is to stop supplying the affected batches immediately and for a quarantine of all remaining stock to be performed so that it can be sent back to the supplier via the approved processes. Action on this alert should be taken within a 48-hour period.
Precise batch numbers of the affected medicines can be found in the official MHRA issued alert.
Source: MHRA
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
